{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:59:35Z","timestamp":1780678775804,"version":"3.54.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,17]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Ketorolac tromethamine injection-induced peptic ulcer with bleeding remains rarely reported in clinical case studies. Controversy persists, particularly regarding its analgesic use in patients with a history of gastric ulcer, even after clinical cure. Herein, this article presents a case of peptic ulcer with bleeding after supra-therapeutic dosage of ketorolac tromethamine injection for post\u2011cholecystectomy analgesia in a patient with a clinically \u201chealed\u201d gastric ulcer, emphasizing the need for cautious and rational prescribing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 70-year-old male patient with a history of peptic ulcer and gallstones presented with recurrent right upper quadrant pain for over 2 years. Previous treatment with oral Xiaoyan Lidan Tablets (an anti-inflammatory and choleretic agent) did not prevent symptom recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Peptic ulcer with bleeding, Gallstones with chronic cholecystitis, Hypertension (Grade 2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient underwent a laparoscopic cholecystectomy under general anesthesia. For postoperative analgesia, intramuscular ketorolac tromethamine injection was administered at 30\u2009mg twice daily, which exceeded the recommended dosage range. Appropriate symptomatic therapies, including anti\u2011infection, hepatoprotection, hemostasis, and fluid replacement therapy, were administered as clinically indicated. On the fourth postoperative day, the patient developed gastrointestinal bleeding with a hemoglobin level of 62\u2009g\/L. Based on the medication history, the gastrointestinal bleeding was considered associated with the application of ketorolac tromethamine injection. The drug was discontinued for observation, and the patient was started on pantoprazole for acid suppression and gastric protection, along with carbazochrome sodium sulfonate for hemostasis. As the gastrointestinal bleeding symptoms did not improve, the regimen was adjusted to esomeprazole for acid suppression and gastric protection, supplemented with hemostatic therapy using somatostatin and hemocoagulase. Following this adjustment, the patient gastrointestinal bleeding symptoms gradually improved.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Gastrointestinal bleeding was controlled, and the patient was discharged following clinical improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case supports a potential causal relationship between the use of ketorolac tromethamine injection and the occurrence of peptic ulcer with bleeding, especially in patients with clinically cured gastric ulcer: a risk often overlooked in drug selection. Particular emphasis should be placed on individualized medication, risk assessment, and multidisciplinary collaboration to enhance patient safety and treatment efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048355","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:01:02Z","timestamp":1776434462000},"page":"e48355","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Ketorolac-induced peptic ulcer bleeding after cholecystectomy in a \u201chealed\u201d ulcer patient: A CARE case report"],"prefix":"10.1097","volume":"105","author":[{"given":"Lifen","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Zigong Third People\u2019s Hospital, Zigong, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Zigong Third People\u2019s Hospital, Zigong, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4823-6782","authenticated-orcid":false,"given":"Shunhua","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Zigong Third People\u2019s Hospital, Zigong, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260605","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1185\/030079906X112471","article-title":"Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.","volume":"22","author":"Waterbury","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"R2-20260605","first-page":"506","article-title":"Safety and precautions of nonsteroidal anti-inflammatory drugs (NSAIDs) in elderly patients.","volume":"22","author":"Rongzhen","year":"2019","journal-title":"Chin J General Pract"},{"key":"R3-20260605","first-page":"187","article-title":"Research on perioperative use and rationality evaluation of NSAIDs.","volume":"17","author":"Xiaolei","year":"2020","journal-title":"Chin J Drug Appl Monit"},{"key":"R4-20260605","first-page":"23","article-title":"Evaluation of perioperative nonsteroidal anti-inflammatory drug (NSAIDs) use and rationality in surgery.","volume":"19","author":"Jinjin","year":"2022","journal-title":"Chin J Rational Drug Use"},{"key":"R5-20260605","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jama.1996.03530290046036","article-title":"Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study.","volume":"275","author":"Strom","year":"1996","journal-title":"JAMA"},{"key":"R6-20260605","first-page":"728","article-title":"Prevention and treatment of stress-mucosal lesions: expert consensus of general surgery in China (2015).","volume":"35","year":"2015","journal-title":"Chin J Pract Surg"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R9-20260605","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/106002809502907-808","article-title":"Gastrointestinal complications associated with intramuscular ketorolac tromethamine therapy in the elderly.","volume":"29","author":"Maliekal","year":"1995","journal-title":"Ann Pharmacother"},{"key":"R10-20260605","first-page":"81","article-title":"Prevention and treatment guidelines for nonsteroidal anti-inflammatory drug-related gastrointestinal ulcers and ulcer complications.","volume":"56","year":"2017","journal-title":"Medline Istic PKU CSCD CA"},{"key":"R11-20260605","doi-asserted-by":"crossref","first-page":"899","DOI":"10.14309\/ajg.0000000000001245","article-title":"ACG clinical guideline: upper gastrointestinal and ulcer bleeding.","volume":"116","author":"Laine","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"R12-20260605","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1016\/j.jemermed.2024.04.007","article-title":"Intravenous acetaminophen versus ketorolac for prehospital analgesia: a retrospective data review.","volume":"67","author":"McArthur","year":"2024","journal-title":"J Emerg Med"},{"key":"R13-20260605","first-page":"53","article-title":"Intravenous acetaminophen and intravenous ketorolac for management of pediatric surgical pain: a literature review.","volume":"82","author":"Baley","year":"2014","journal-title":"AANA J"},{"key":"R14-20260605","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(02)07273-2","article-title":"Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.","volume":"359","author":"Huang","year":"2002","journal-title":"Lancet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:00:23Z","timestamp":1780675223000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":13,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048355","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"2025-09-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}